| Statin use and risk of cirrhosis and related complications in patients with chronic liver diseases: a systematic review and meta-analysis RG Kim, R Loomba, LJ Prokop, S Singh Clinical gastroenterology and hepatology 15 (10), 1521-1530. e8, 2017 | 179 | 2017 |
| Age-related disease association of endogenous γ-H2AX foci in mononuclear cells derived from leukapheresis SH Schurman, CA Dunn, R Greaves, B Yu, L Ferrucci, DL Croteau, ... Public Library of Science 7 (9), e45728, 2012 | 35 | 2012 |
| Magnetic resonance elastography identifies fibrosis in adults with alpha‐1 antitrypsin deficiency liver disease: a prospective study RG Kim, P Nguyen, R Bettencourt, PS Dulai, W Haufe, J Hooker, ... Alimentary Pharmacology & Therapeutics 44 (3), 287-299, 2016 | 34 | 2016 |
| Probing the Binding Site of the A1 Adenosine Receptor Reengineered for Orthogonal Recognition by Tailored Nucleosides KK Palaniappan, ZG Gao, AA Ivanov, R Greaves, H Adachi, P Besada, ... Biochemistry 46 (25), 7437-7448, 2007 | 20 | 2007 |
| Fatty liver and the coronavirus disease 2019 pandemic: health behaviors, social factors, and telemedicine satisfaction in vulnerable populations RG Kim, SP Medina, C Magee, M Khalili Hepatology communications 6 (5), 1045-1055, 2022 | 15 | 2022 |
| TRP53 mutants drive neuroendocrine lung cancer through loss-of-function mechanisms with gain-of-function effects on chemotherapy response N Akeno, AL Reece, M Callahan, AL Miller, RG Kim, D He, A Lane, ... Molecular cancer therapeutics 16 (12), 2913-2926, 2017 | 13 | 2017 |
| Syntheses of alpha-and beta-C-glucopyranosyl serines from a common intermediate. EG Nolen, LA Donahue, R Greaves, TA Daly, DR Calabrese Organic Letters 10 (21), 4911-4914, 2008 | 12 | 2008 |
| Noninvasive fibrosis screening in fatty liver disease among vulnerable populations: impact of diabetes and obesity on FIB-4 score accuracy RG Kim, J Deng, JN Reaso, JP Grenert, M Khalili Diabetes Care 45 (10), 2449-2451, 2022 | 8 | 2022 |
| A pilot study to understand and respond to loss, theft, and misplacement of hepatitis C treatment medication for people who inject drugs MD Morris, C McDonell, RG Kim, Y Laguardia, R Kanner, JC Price Clinical Liver Disease 22 (3), 81-84, 2023 | 2 | 2023 |
| Cross‐sectional study on stigma and motivation to adhere to lifestyle modification among vulnerable populations with fatty liver disease SP Medina, RG Kim, C Magee, N Stapper, M Khalili Obesity Science & Practice 9 (6), 581-589, 2023 | 1 | 2023 |
| Undiagnosed abnormal alanine transaminase levels in vulnerable populations: Impact of sex, race/ethnicity, and body mass RG Kim, M Khalili Obesity Science & Practice 9 (2), 190-199, 2023 | 1 | 2023 |
| Racial/ethnic differences in fibrosis prevalence and progression in biopsy‐proven steatosis: A focus on the Asian American population RG Kim, JN Chu, E Vittinghoff, J Deng, JN Reaso, JP Grenert, M Khalili Hepatology Communications 6 (11), 3024-3035, 2022 | 1 | 2022 |
| Telemedicine acceptability and experience in a marginalized population at high-risk for HCV R Kim, S Burbank, C McDonell, M Morris, JC Price Hepatology 74, 409A-409A, 2021 | 1 | 2021 |
| Recurrent lower gastrointestinal bleeding due to a cholecystocolonic fistula C Kraft, RG Kim, P Kathpalia Official journal of the American College of Gastroenterology| ACG 116 (9), 1825, 2021 | 1 | 2021 |
| Tu1621 OUTCOMES OF LIVER TRANSPLANTION IN SEVERE ACUTE ALCOHOLICASSOCIATED HEPATITIS AND ALCOHOL-ASSOCIATED CIRRHOSIS AT THE UNIVERSITY OF UTAH TRANSPLANT CENTER CW McDaniel, B Ofori-Atta, RG Kim, JF Gallegos-Orozco Gastroenterology 166 (5), S-1750, 2024 | | 2024 |
| Staff-Facilitated Telemedicine Care Delivery for Treatment of Hepatitis C Infection among People Who Inject Drugs RG Kim, C McDonell, J McKinney, L Catalli, JC Price, MD Morris Healthcare 12 (7), 715, 2024 | | 2024 |
| Telehepatology Satisfaction Is Associated with Ethnicity: The Real-World Experience of a Vulnerable Population with Fatty Liver Disease RG Kim, S Patel, DD Satre, M Shumway, JY Chen, C Magee, RJ Wong, ... Digestive Diseases and Sciences 69 (3), 732-742, 2024 | | 2024 |
| A framework for approaching hepatitis C reinfection in people who use drugs RG Kim, JC Price Clinical Liver Disease 23 (1), e0200, 2024 | | 2024 |
| Screening for Social Determinants of Health Among Populations at Risk for MASLD: A Scoping Review RG Kim, A Ballantyne, MB Conroy, JC Price, JM Inadomi Frontiers in Public Health 12, 1332870, 2024 | | 2024 |
| Fatty Liver Education Promotes Physical Activity in Vulnerable Groups, Including Those With Unhealthy Alcohol Use S Patel, RG Kim, AM Shui, C Magee, M Lu, J Chen, M Tana, CY Huang, ... Gastro Hep Advances 3 (1), 84-94, 2024 | | 2024 |
Rohit Loomba, MD, MHScUniversity of California at San Diego在 health.ucsd.edu 的电子邮件经过验证
